公开(公告)号：EP1187601B1

公开(公告)日：2005-07-27

申请号：EP00935151.1

申请日：2000-05-31

申请人： ALTANA Pharma AG

发明人： DIETRICH, Rango ,  LINDER, Rudolf

IPC分类号： A61K9/16 ,  A61K31/4439

CPC分类号： A61K31/4439 ,  A61K9/0007 ,  A61K9/009 ,  A61K9/0095 ,  A61K9/1617 ,  A61K9/1623 ,  A61K9/1635 ,  A61K9/1652 ,  A61K9/1694 ,  A61K9/2077 ,  A61K9/2095 ,  A61K9/5084

摘要： Novel administration forms and preparations for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present in the active compound units in a matrix made of a mixture comprising at least one fatty alcohol and at least one solid paraffin, in a matrix made of a mixture of a triglyceride and at least one solid paraffin or in a matrix made of a mixture comprising at least one fatty acid ester and at least one solid paraffin. In particular, the active compound units are microspheres which can be produced by prilling.

公开(公告)号：EP1341524A2

公开(公告)日：2003-09-10

申请号：EP01991781.4

申请日：2001-12-05

申请人： ALTANA Pharma AG

发明人： DIETRICH, Rango ,  LINDER, Rudolf

IPC分类号： A61K9/16 ,  A61K31/4439

CPC分类号： A61K31/4439 ,  A61K9/0056 ,  A61K9/06 ,  A61K9/1617 ,  A61K9/5015

摘要： The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also relates to processes for producing the paste. The paste is particularly suitable for administering acid-labile active ingredients to animals or to people who have difficulty taking solid dosage forms such as tablets or capsules.

公开(公告)号：EP1341523A1

公开(公告)日：2003-09-10

申请号：EP01985365.4

申请日：2001-12-05

申请人： ALTANA Pharma AG

发明人： DIETRICH, Rango ,  LINDER, Rudolf

IPC分类号： A61K9/16 ,  A61K9/10 ,  A61K31/44

CPC分类号： A61K9/0095 ,  A61K9/1617 ,  A61K31/4439

摘要： The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also relates to processes for producing the suspension. The suspension is particularly suitable for administering acid-labile active ingredients to people who have difficulty taking solid dosage forms such as tablets or capsules.